## Abstract We previously reported that inoculation of rats with live vaccinia virus (VV) recombinants VVpyMT, VVpyLT expressing either the middle‐T (MT) or large‐T (LT) proteins of polyomavirus (PyV) can elicit immunity to challenge with syngeneic PyV‐tumor cells. We now report the results of cros
Studies on the polyoma-virus-induced tumor-specific transplantation antigen (TSTA) - does middle or large T-antigen play a role?
✍ Scribed by Tina Dalianis; Torbjörn Ramqvist; George Klein
- Publisher
- John Wiley and Sons
- Year
- 1984
- Tongue
- French
- Weight
- 347 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Mice and rats could be immunized against the polyoma-virus-induced tumor-specific transplantation antigen (TSTA) by repeated inoculation of frozen or irradiated cells of an MT-cDNA-transformed rat cell line (2.8) that contains only the polyoma middle T-antigen, or by cells that carried a host range mutant and expressed a full-length large T-antigen, but only non-functional N-terminal fragments of small and middle T. This shows that neither large T nor an intact middle T is necessary to elicit a polyoma tumor-specific graft rejection response. Either one of them is sufficient by itself.
📜 SIMILAR VOLUMES